[HTML][HTML] SLC8A1, a novel prognostic biomarker and immunotherapy target in RSA and UCEC based on scRNA-seq and pan-cancer analysis

J Chu, X Qin, W Chen, Z Xu, X Xu - Heliyon, 2024 - cell.com
Background The field of gynaecological immunology has increasingly focused on recurrent
spontaneous abortion (RSA). The complex mechanisms underlying the interaction between …

[HTML][HTML] Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer

Y Wang, K Wang, H Zhang, X Jia, X Li, S Sun… - Frontiers in …, 2023 - frontiersin.org
Introduction: SLC2A1, a member of the SLC transporter family, is involved in a variety of cell
death modalities and has been found to be associated with the prognosis and immune …

[HTML][HTML] SLC1A4: a powerful prognostic marker and promising therapeutic target for HCC

X Peng, R Chen, S Cai, S Lu, Y Zhang - Frontiers in oncology, 2021 - frontiersin.org
SLC1A4, a Na-dependent neutral amino acid transporter, was considered to participate in
the various pathobiological process, including tumorigenesis. However, the correlation …

[HTML][HTML] Clinical value of SLC12A9 for diagnosis and prognosis in colorectal cancer

W Du, G Xia, L Chen, L Geng, R Xu, Q Han… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Objective: The goal of the study is to assess the clinical value and the potential mechanism
of SLC12A9 combing transcriptome and single cell sequencing data. Methods: In this study …

[HTML][HTML] SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics

K Xu, Y Wu, H Chi, Y Li, Y She, X Yin, X Liu, B He, X Li… - Medicine, 2022 - journals.lww.com
Clear cell renal cell carcinoma (ccRCC) is one of the most common renal malignancies
worldwide. SLC22A8 plays a key role in renal excretion of organic anions. However, its role …

[HTML][HTML] Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC

S Jiang, J Zou, J Dong, H Shi, J Chen, Y Li… - Cell Communication and …, 2023 - Springer
Background Solute carrier family 7 member 2 (SLC7A2), a cationic amino acid transporter, is
lowly expressed in ovarian and hepatocellular cancers, which is associated with their worse …

[HTML][HTML] SLC2A1 plays a significant prognostic role in lung adenocarcinoma and is associated with tumor immunity based on bioinformatics analysis

Y Wang, H Wen, D Sun - Annals of Translational Medicine, 2022 - ncbi.nlm.nih.gov
Background The treatment of lung adenocarcinoma (LUAD) has been stuck in a bottleneck
due to a number of factors. There is a pressing need for research into potential genetic …

Identification of SLC12A8 as a valuable prognostic biomarker and immunotherapeutic target by comprehensive pan-cancer analysis

D Yu, H Ma, D Li, H Tang, W Li, M Li - Gene, 2024 - Elsevier
Solute carrier family 12 member 8 (SLC12A8) is a nicotinamide mononucleotide transporter.
Despite emerging evidence supporting its potential involvement in oncogenesis, a …

[HTML][HTML] SLC31A1 identifying a novel biomarker with potential prognostic and immunotherapeutic potential in pan-cancer

P Zhang, H Yang, K Zhu, C Chang, W Lv, R Li, X Li… - Biomedicines, 2023 - mdpi.com
Solute carrier family 31 member 1 (SLC31A1) encodes a protein that functions as a
homotrimer for the uptake of dietary copper. As a vital member of the cuproptosis gene …

[HTML][HTML] SLC1A5 prefers to play as an accomplice rather than an opponent in pancreatic adenocarcinoma

F Xu, H Wang, H Pei, Z Zhang, L Liu, L Tang… - Frontiers in Cell and …, 2022 - frontiersin.org
Background: SLC1A5, a ferroptosis regulator gene, plays a dual role in cancer regulation.
However, the roles of SLC1A5 in pancreatic adenocarcinoma (PAAD) remain elusive …